Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Life-long overexpression of S100β in Down’s syndrome: implications for Alzheimer pathogenesis

1 Sept 1998

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Neonatal Respiratory Health Research
Share to S100 Proteins and Annexins

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 9880042
DOI: 10.1016/s0197-4580(98)00074-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Life-long overexpression of S100β in Down’s syndrome: implications for Alzheimer pathogenesisPMID 9880042Read ↗

Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's diseaseSemantic proximity Read ↗

Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: Insights from proteomicsSemantic proximity Read ↗

Aging with Down Syndrome—Where Are We Now and Where Are We Going?Semantic proximity Read ↗

Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic interventionSemantic proximity Read ↗

HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathologySemantic proximity Read ↗

Dementia in Down syndrome: unique insights for Alzheimer disease researchSemantic proximity Read ↗

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) StudySemantic proximity Read ↗

Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down SyndromeSemantic proximity Read ↗

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional studySemantic proximity Read ↗

Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin BSemantic proximity Read ↗

microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageingSemantic proximity Read ↗

Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.